| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 55 | 91 | -3.30 | 0.87 | BLENDED GS |
| May 2025 | 103 | 91 | -5.95 | 2.23 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 55 | 91 | -3.30 | 0.87 | BLENDED GS |
| May 2025 | 103 | 91 | -5.95 | 2.23 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 63 | 20 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 23 | 77 | 1188 | 387 | 401 | 74 | 77 |
| May 2025 | 21 | 71 | 1125 | 386 | 402 | 74 | 78 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 23 | 77 | 1188 | 387 | 401 | 74 | 77 |
| May 2025 | 21 | 71 | 1125 | 386 | 402 | 74 | 78 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 75 | 51 | 28 | 10 | 1 |
| No. Herds | 21 | 20 | 14 | 8 | 1 |
| No. without completed record | 2 | 14 | 9 | 6 | 5 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 75 | 51 | 28 | 10 | 1 |
| No. Herds | 21 | 20 | 14 | 8 | 1 |
| No. without completed record | 2 | 14 | 9 | 6 | 5 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 63 | 20 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 85 | 15 |
| CAN | 116 | 61 | 130 | 60 |
| DFS | 0 | 0 | 0 | 0 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 1914 | 371 | 2626 | 415 |
| GER | 33 | 14 | 46 | 15 |
| ITA | 839 | 210 | 870 | 205 |
| NLD | 0 | 0 | 0 | 0 |
| NZL | 271 | 29 | 72 | 15 |
| USA | 0 | 0 | 647 | 102 |